Mepolizumab significantly reduced the annualized rate of moderate or severe exacerbations in COPD with an eosinophilic ...

GSK has highlighted approval of Nucala in COPD as one of its top 2025 priorities, adding to its established medicines for the ...

With mepolizumab vs. placebo, patients with COPD and type 2 inflammation experienced significantly fewer moderate/severe ...

Virtual pulmonary rehabilitation is a safe, effective alternative to traditional pulmonary rehabilitation programs for people ...

Virtual pulmonary rehabilitation is a safe, effective alternative to traditional pulmonary rehabilitation programs for people ...

Researchers have developed a novel rat model that closely replicates the pathological features and physiological changes ...

Phase III trial data published in The New England Journal of Medicine support Nucala’s role as an add-on biologic therapy to ...

Last year, the FDA approved the biologic drug Dupixent to treat uncontrolled eosinophilic COPD. The approval marked a step ...

COPD is a disease that damages your lungs over time. It may start with mild symptoms and then get worse. Treatment can help symptoms and slow disease progression. Chronic obstructive pulmonary ...

Dust storms in El Paso are more than just a nuisance. Discover the health risks and expert advice on staying safe.

Researchers have identified in a new study that sole e-cigarette use is strongly linked with the risk of chronic obstructive ...

AstraZeneca has taken a key step in advancing Breztri Aerosphere toward a potential label expansion and achieving its goal of ...